Bilateral Deals: The End of Humanitarianism?
Picture this: A rural health clinic in Malawi, once bustling with hope thanks to American-funded HIV treatments, now faces uncertainty as U.S. dollars are pulled back or come with new strings attached. The Trump administration’s sweeping overhaul of global health aid, which pivots from broad, multilateral initiatives to tightly negotiated bilateral agreements, signals a seismic shift—not just in method, but in America’s fundamental approach to global responsibility.
Secretary of State Marco Rubio emphasized that the United States remains committed to being the world’s most generous nation in health funding—but only when such generosity serves the so-called “interests of Americans.” That’s a dramatic rethink of decades-old bipartisan consensus, where humanitarian imperative was paramount and public health aid was a diplomatic bridge, not a transactional bartering chip.
This policy revamp doesn’t emerge in a vacuum. It follows the dismantling of the U.S. Agency for International Development (USAID) and drastic funding cuts—decisions that left experts worldwide sounding the alarm. “Shortchanging health aid at a time of resurgent pandemics is both dangerously myopic and inconsistent with American ideals,” warns Dr. Jennifer Kates of the Kaiser Family Foundation. These cuts undermined flagship programs like PEPFAR (the President’s Emergency Plan for AIDS Relief), credited with saving more than 25 million lives since its inception in 2003, according to State Department records.
The Transactional Turn: What’s Really at Stake?
With the new bilateral strategy, aid is no longer guaranteed—instead, it’s the subject of negotiations, cost-sharing, and regional prioritization, shifting away from the needs of recipient nations toward what’s defined as U.S. national interest. The plan is explicit: the United States will cover frontline healthcare worker costs only until the start of the next fiscal year, at which point recipient nations must take on a greater share of the financial burden. This “teach a man to fish” approach may sound pragmatic, but it raises acute questions about equity and long-term stability.
Advocates for global health fear the new approach will create deep disparities. Wealthier countries—or those deemed more strategically valuable—stand to reap greater benefits. Meanwhile, the most vulnerable could see lifelines cut off. Harvard global health expert Dr. Paul Farmer once asserted, “Health is a human right, not a privilege reserved for the lucky or the strategically useful.” Yet under this model, access depends on a government’s negotiating clout and willingness to co-invest, not on the scale of need. That’s a recipe for widening global health divides.
“By shifting from established multilateral efforts to transactional bilateral deals, the U.S. is sending a clear message: humanitarian objectives are secondary to political calculation. The world’s most vulnerable populations may pay the price.” — Dr. Jennifer Kates, Kaiser Family Foundation
The administration defends this cost-sharing model as an antidote to waste. But a closer look reveals a far more complex reality. Many of the poorest nations receiving U.S. health aid are simply unable to “graduate” to self-sufficiency overnight; expecting them to do so risks abrupt care disruptions, medicine shortages, and reversed progress against epidemics like HIV and tuberculosis. According to a 2023 study published in The Lancet, sudden drawdowns of external health funding have historically led to increased mortality and outbreaks—outcomes at odds with both humanitarian morals and enlightened self-interest.
Beyond Aid: Repercussions for U.S. Influence and Global Health Security
Beneath the rhetoric of efficiency and “getting more for less” lurks an uncomfortable truth: America’s global standing hinges on more than deal-making prowess. Foreign aid, particularly in public health, is one of the most potent levers the U.S. has to build goodwill, promote stability, and prevent security threats from festering abroad. Slashing support and attaching short-term, transactional conditions may yield short-lived savings, but it severely undermines the strategic depth and trust that global leadership demands.
Longtime partners, especially across sub-Saharan Africa and Southeast Asia, now worry the U.S. is abandoning not just programs, but principles. Public health professionals warned of the chilling effect as direct aid is replaced by “third-country” partnerships, often using allies as intermediaries to deliver assistance. This added bureaucratic layer risks losing sight of the people most in need, as priorities get diluted and accountability becomes even harder to enforce.
Consider how global health crises rarely respect borders. The COVID-19 pandemic, which took the world by storm in 2020, exposed the glaring risks of fragmented, narrowly defined aid. “Pandemics are not local problems. They’re global threats,” notes Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases. The pandemic showed how failing to support robust health infrastructures abroad rebounds on American shores—shattered supply chains, uncontrolled contagion, and urgent humanitarian crises that can’t be solved from Washington alone.
Progressive values—solidarity, equity, and foresight—demand more than piecemeal reform. They require affirming that American leadership is measured not by the size of strings attached to its aid, but by the ability to lift others up with no expectation of direct return. Expert after expert warns: centering foreign health assistance on “America First” profoundly risks leaving millions behind, endangering not just global well-being but our own future security.
